Breast Cancer Patient Outcomes and Costs for Value-Based Healthcare Analysis

330 patients diagnosed with breast cancer were followed for 12 months across two healthcare centers to demonstrate a novel value-based healthcare methodology. The study introduces Patient-centred Outcome-Adjusted Life Years (PACELYs) and incremental value calculations, with costs ranging from 12,129€ to 13,404€. This proof-of-concept dataset was authored by Borja García-Lorenzo and last updated in April 2026.

Use Cases

• Benchmarking healthcare provider efficiency based on patient-reported outcomes and cost data.
• Calculating incremental value (IV) and value curves for decision-making in healthcare management.
• Applying the PACELYs metric to other medical conditions for comparative value analysis.

Strengths

• Includes a cohort of 330 patients with a 12-month follow-up period.
• Provides specific cost figures (12,129€–13,404€) and PACELYs scores (69.85–73.24) for two healthcare centers.
• Released under a permissive CC-BY-4.0 license.

Limitations

• Dataset scale is limited to 53.5 KB; row count and column-level documentation are unknown.
• Data is specific to breast cancer patients from two centers, which may limit generalizability.
• The primary file format is DOCX, which may require extraction for structured analysis.

Provenance

Source

Borja García-Lorenzo via figshare

Collection Method

Patient-reported outcomes and economic-related outcomes collected from a cohort across two healthcare centers.

Time Range

Follow-up period of 12 months for the patient cohort.

Freshness

Last updated 2026-04-13 12:52:55

Geography

Healthcare centers are not specified; likely reflects a specific regional or national context.